Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Kiichiro Kaji"'
Publikováno v:
JGH Open, Vol 7, Iss 12, Pp 1006-1008 (2023)
Abstract The mechanisms underlying the progression of intracholecystic papillary neoplasms (ICPNs) to gallbladder cancer and invasive cancer remain relatively unclear. In the present case, metastatic liver tumors were suspected in an 83‐year‐old
Externí odkaz:
https://doaj.org/article/e28e6c5db0a04a1580e2f1b8276f9539
Autor:
Yuji Hodo, Hajime Takatori, Takuya Komura, Yoshiro Asahina, Tomoyoshi Chiba, Hisashi Takabatake, Kenkei Hasatani, Ryuhei Nishino, Masaaki Yano, Yoshiko Takata, Tsuyoshi Suda, Haruhiko Shugo, Hiroyoshi Nakanishi, Kazutoshi Yamada, Kazuhiro Miwa, Kiichiro Kaji, Masaki Nishitani, Masaki Miyazawa, Taro Yamashita
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 16 (2023)
Background: Endoscopic gastroduodenal stent (GDS) placement is widely used as a safe and effective method to rapidly improve gastrointestinal symptoms of malignant gastric outlet obstruction (MGOO). While previous studies reported the utility of chem
Externí odkaz:
https://doaj.org/article/47740c39860b46e1959e3d2263c8eace
Autor:
Tsuyoshi Suda, Hajime Takatori, Takehiro Hayashi, Kiichiro Kaji, Kouki Nio, Takeshi Terashima, Tetsuro Shimakami, Kuniaki Arai, Tatsuya Yamashita, Eishiro Mizukoshi, Masao Honda, Kenichiro Okumura, Kazuto Kozaka, Taro Yamashita
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 9, p 7732 (2023)
Liver function influences the plasma antithrombin (AT)-III levels. AT-III is beneficial for patients with portal vein thrombosis (PVT) and low plasma AT-III levels. However, whether these levels affect prognosis in patients with cirrhosis-associated
Externí odkaz:
https://doaj.org/article/d4567c635d8449c99f5be47ed8f34a6f
Autor:
Daisuke Yamamiya, Eishiro Mizukoshi, Kiichiro Kaji, Takeshi Terashima, Masaaki Kitahara, Tatsuya Yamashita, Kuniaki Arai, Kazumi Fushimi, Masao Honda, Shuichi Kaneko
Publikováno v:
PLoS ONE, Vol 13, Iss 6, p e0198264 (2018)
BACKGROUND & AIMS:Many individuals are infected with hepatitis B virus (HBV) worldwide, and this virus is commonly controlled by treatments with interferon (IFN)-alpha and nucleoside analogues (NA). However, the complete elimination of HBV by these t
Externí odkaz:
https://doaj.org/article/db49c641e1bf476782dd282b6dac12cc
Autor:
Kiichiro Kaji, Eishiro Mizukoshi, Tatsuya Yamashita, Kuniaki Arai, Hajime Sunagozaka, Kazumi Fushimi, Hidetoshi Nakagawa, Kazutoshi Yamada, Takeshi Terashima, Masaaki Kitahara, Shuichi Kaneko
Publikováno v:
PLoS ONE, Vol 12, Iss 1, p e0170291 (2017)
Squamous cell carcinoma antigen recognized by T cells 3 (SART3), a tumor-associated antigen expressed in many cancers, functions in tumor rejection. In this study, we investigated its usefulness as an immunotherapeutic target in hepatocellular carcin
Externí odkaz:
https://doaj.org/article/177c0a26de6145ebaf3118a27ec4db4a
Publikováno v:
Endoscopy. 55:E700-E701
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3f5ea3e6619ae5f80118cb869c43faac
https://doi.org/10.1055/a-2068-8606
https://doi.org/10.1055/a-2068-8606
Autor:
Masatoshi Yamato, Yohei Marukawa, Takashi Kagaya, Ryotaro Nakai, Kiichiro Kaji, Kiyoki Kitagawa, Takuya Komura, Hajime Ohta, Masashi Unoura, Shuichi Kaneko, Atsuhiro Kawashima, Jun Seishima, Masaki Miyazawa
Publikováno v:
Internal Medicine. 55:1923-1927
Tocilizumab, an anti-human interleukin 6 receptor (IL-6R) monoclonal antibody, is widely used to treat rheumatoid arthritis (RA) and is expected to exhibit clinical efficacy when used to treat other autoimmune diseases. However, a risk of opportunist
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::952eda3d3ee3ea07ff231b351e019c8b
https://doi.org/10.2169/internalmedicine.55.5981
https://doi.org/10.2169/internalmedicine.55.5981
Autor:
Tatsuya Yamashita, Masao Honda, Eishiro Mizukoshi, Kuniaki Arai, Kazumi Fushimi, Takeshi Terashima, Daisuke Yamamiya, Masaaki Kitahara, Shuichi Kaneko, Kiichiro Kaji
Publikováno v:
PLoS ONE
PLoS ONE, Vol 13, Iss 6, p e0198264 (2018)
PLoS ONE, Vol 13, Iss 6, p e0198264 (2018)
Background & aims Many individuals are infected with hepatitis B virus (HBV) worldwide, and this virus is commonly controlled by treatments with interferon (IFN)-alpha and nucleoside analogues (NA). However, the complete elimination of HBV by these t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36a0c1afbb3929dc5dec44cfe6faff36
https://doi.org/10.1371/journal.pone.0198264
https://doi.org/10.1371/journal.pone.0198264
Autor:
Satomi Kasashima, Masaaki Yano, Takuya Komura, Masaki Miyazawa, Masatoshi Yamato, Kiichiro Kaji, Jun Seishima, Atsuhiro Kawashima, Masashi Unoura, Yohei Marukawa, Hajime Ohta
Publikováno v:
Clinical journal of gastroenterology. 9(1)
A man in his 60s visited our hospital because of a pancreatic head tumor. Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) revealed that the tumor consisted of a neuroendocrine carcinoma (NEC) and adenocarcinoma, including signet-ring ce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75794388e2a4e6e90fd7a241c6f3e60e
https://pubmed.ncbi.nlm.nih.gov/26848585
https://pubmed.ncbi.nlm.nih.gov/26848585
Autor:
Eishiro Mizukoshi, Kuniaki Arai, Masaaki Kitahara, Hajime Sunagozaka, Kazumi Fushimi, Takeshi Terashima, Tatsuya Yamashita, Kiichiro Kaji, Shuichi Kaneko, Hidetoshi Nakagawa, Kazutoshi Yamada
Publikováno v:
PLoS ONE
PLoS ONE, Vol 12, Iss 1, p e0170291 (2017)
PLoS ONE, Vol 12, Iss 1, p e0170291 (2017)
Background & aims Squamous cell carcinoma antigen recognized by T cells 3 (SART3), a tumor-associated antigen expressed in many cancers, functions in tumor rejection. In this study, we investigated its usefulness as an immunotherapeutic target in hep
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a961c1ee935157c7ef971b2fbc50a10
https://doi.org/10.1371/journal.pone.0170291
https://doi.org/10.1371/journal.pone.0170291